| De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock J Garnacho-Montero, A Gutiérrez-Pizarraya, A Escoresca-Ortega, ... Intensive care medicine 40, 32-40, 2014 | 507 | 2014 |
| Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis J Garnacho-Montero, MJ Huici-Moreno, A Gutiérrez-Pizarraya, I López, ... Critical care 18, 1-9, 2014 | 197 | 2014 |
| Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre. JM Cisneros, O Neth, MV Gil‐Navarro, JA Lepe, F Jiménez‐Parrilla, ... Clin Microbiol Infect, 1469-0691.12191, 2013 | 168 | 2013 |
| Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality J Garnacho-Montero, A Gutiérrez-Pizarraya, A Escoresca-Ortega, ... Critical care 19, 1-8, 2015 | 112 | 2015 |
| Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii J Garnacho-Montero, R Amaya-Villar, A Gutiérrez-Pizarraya, ... Chemotherapy 59 (3), 225-231, 2014 | 104 | 2014 |
| Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave A Gutiérrez-Pizarraya, P Pérez-Romero, R Alvarez, TA Aydillo, ... Journal of Infection 65 (5), 423-430, 2012 | 101 | 2012 |
| Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections: a quasi-experimental study … J Molina, G Peñalva, MV Gil-Navarro, J Praena, JA Lepe, ... Clinical Infectious Diseases 65 (12), 1992-1999, 2017 | 89 | 2017 |
| Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect … F Fernández-Cuenca, M Tomás, FJ Caballero-Moyano, G Bou, ... Journal of Antimicrobial Chemotherapy 70 (12), 3222-3229, 2015 | 80 | 2015 |
| Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority … | 65* | |
| Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia J Garnacho-Montero, R Amaya-Villar, C Ferrándiz-Millón, A Díaz-Martín, ... Expert review of anti-infective therapy 13 (6), 769-777, 2015 | 54 | 2015 |
| Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis C Morata-Tarifa, MM Macías-Sánchez, A Gutiérrez-Pizarraya, ... Stem Cell Research & Therapy 11, 1-12, 2020 | 50 | 2020 |
| The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant … T Amat, A Gutiérrez-Pizarraya, I Machuca, I Gracia-Ahufinger, ... Clinical Microbiology and Infection 24 (6), 630-634, 2018 | 49 | 2018 |
| Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality J Garnacho-Montero, A Gutiérrez-Pizarraya, A Díaz-Martín, ... Enfermedades infecciosas y microbiologia clinica 34 (9), 551-558, 2016 | 45 | 2016 |
| Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients J Molina, I Penuela, JA Lepe, A Gutierrez-Pizarraya, MJ Gomez, ... Journal of Infection 66 (2), 155-162, 2013 | 43 | 2013 |
| Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive … J Garnacho-Montero, C León-Moya, A Gutiérrez-Pizarraya, ... Journal of critical care 48, 172-177, 2018 | 27 | 2018 |
| Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis A Gutiérrez-Pizarraya, M Leone, J Garnacho-Montero, C Martin, ... Expert Review of Clinical Pharmacology 10 (4), 457-465, 2017 | 24 | 2017 |
| Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain MD Cantudo-Cuenca, A Gutierrez-Pizarraya, A Pinilla-Fernandez, ... Scientific Reports 11 (1), 12414, 2021 | 23 | 2021 |
| Randomized, Double-Blind, Controlled Trial, Phase III, to Evaluate the Use of Platelet-Rich Plasma Versus Hyaluronic Acid in Hip Coxarthrosis Rev Esp Cir Ortop Traumatol, 2020 | 21 | 2020 |
| High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment J Macías, A Pinilla, FA Lao-Dominguez, A Corma, E Contreras-Macias, ... Scientific Reports 10 (1), 20958, 2020 | 20 | 2020 |
| Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool G Martín-Gutiérrez, C Martín-Pérez, A Gutiérrez-Pizarraya, JA Lepe, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 35 (10), 638-644, 2017 | 20 | 2017 |
JOSE GARNACHO-MONTEROIntensive Care Clinical Unit. University Hospital Virgen Macarena Seviile, Spain在 juntadeandalucia.es 的电子邮件经过验证
